Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1651534 (Pf-04457845, PF-04457845, PF-4457845, Redafamdastat) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
α2C-adrenoceptor/Alpha-2c adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1916] [GtoPdb: 27] [UniProtKB: P18825] | ||||||||
ChEMBL | GPCRScan assay: inhibition of Alpha2C | B | 6.22 | pKi | 602.56 | nM | Ki | Data for DCP probe PF-04457845 |
ChEMBL | GPCRScan assay: inhibition of Alpha2C | B | 6.23 | pKi | 595.66 | nM | Ki | Data for DCP probe PF-04457845 |
ChEMBL | Selectivity interaction (GPCR panel (PDSP screen)) EUB0000306b ADRA2C | B | 6.23 | pKi | 595.66 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
Fatty acid amide hydrolase/Anandamide amidohydrolase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2243] [GtoPdb: 1400] [UniProtKB: O00519] | ||||||||
ChEMBL | Selectivity interaction (HERG functional (IKr) voltage clamp assay) EUB0000306b FAAH | B | 5.33 | pIC50 | 4700 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | Glutamate dehydrogenase-coupled FAAH assay (preincubation time 1 min) | B | 7.3 | pIC50 | 50.4 | nM | IC50 | Data for DCP probe PF-04457845 |
ChEMBL | Glutamate dehydrogenase-coupled FAAH assay (preincubation time 15 min) | B | 7.49 | pIC50 | 32.4 | nM | IC50 | Data for DCP probe PF-04457845 |
ChEMBL | Glutamate dehydrogenase-coupled FAAH assay (preincubation time 30 min) | B | 7.97 | pIC50 | 10.7 | nM | IC50 | Data for DCP probe PF-04457845 |
ChEMBL | Glutamate dehydrogenase-coupled FAAH assay (preincubation time 60 min) | B | 8.13 | pIC50 | 7.4 | nM | IC50 | Data for DCP probe PF-04457845 |
ChEMBL | Inhibition of His-tagged human FAAH N-terminal transmembrane-deleted truncated form expressed in Escherichia coli preincubated for 60 mins before oleamide substrate addition | B | 8.14 | pIC50 | 7.2 | nM | IC50 | ACS Med Chem Lett (2011) 2: 91-96 [PMID:21666860] |
ChEMBL | Affinity Biochemical interaction (Glutamate dehydrogenase-coupled FAAH assay (preincubation time 60 min)) EUB0000306b FAAH | B | 8.14 | pIC50 | 7.2 | nM | IC50 | Affinity Biochemical Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | Inhibition of human transmembrane domain deficient FFAH expressed in Escherichia coli using AAMCA as substrate incubated for 1 min measured for 50 mins by fluorescence assay | B | 8.74 | pIC50 | 1.8 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 238-243 [PMID:30503633] |
GtoPdb | Inhibition of human FAAH in vitro. | - | 9 | pIC50 | 1 | nM | IC50 |
ACS Med Chem Lett (2011) 2: 91-96 [PMID:21666860]; Science (2017) 356: 1084-1087 [PMID:28596366] |
Fatty acid amide hydrolase/Anandamide amidohydrolase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3229] [GtoPdb: 1400] [UniProtKB: P97612] | ||||||||
ChEMBL | Irreversible inhibition of His-tagged rat FAAH N-terminal transmembrane-deleted truncated form expressed in Escherichia coli preincubated for 60 mins before oleamide substrate addition | B | 8.13 | pIC50 | 7.4 | nM | IC50 | ACS Med Chem Lett (2011) 2: 91-96 [PMID:21666860] |
ChEMBL | Inhibition of rat FFAH expressed in Escherichia coli using AAMCA as substrate incubated for 1 min measured for 50 mins by fluorescence assay | B | 8.24 | pIC50 | 5.7 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 238-243 [PMID:30503633] |
CB1 receptor/Cannabinoid CB1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL218] [GtoPdb: 56] [UniProtKB: P21554] | ||||||||
ChEMBL | CB1 (h) CEREP ligand profiling | B | 4.85 | pKi | 14000 | nM | Ki | Data for DCP probe PF-04457845 |
CB2 receptor/Cannabinoid CB2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL253] [GtoPdb: 57] [UniProtKB: P34972] | ||||||||
ChEMBL | CB2 (h) CEREP ligand profiling | B | 5.29 | pKi | 5100 | nM | Ki | Data for DCP probe PF-04457845 |
GABAA receptor α1 subunit/GABA receptor alpha-1 subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1962] [GtoPdb: 404] [UniProtKB: P14867] | ||||||||
ChEMBL | Selectivity interaction (GPCR panel (PDSP screen)) EUB0000306b GABRA1 | B | 5.94 | pKi | 1140.08 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
5-HT2A receptor/Serotonin 2a (5-HT2a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL224] [GtoPdb: 6] [UniProtKB: P28223] | ||||||||
ChEMBL | 5-HT2A (h) (agonist site) CEREP ligand profiling | B | 5.8 | pKi | 1600 | nM | Ki | Data for DCP probe PF-04457845 |
ChEMBL | Selectivity interaction (CEREP ligand profiling panel (ion channels, GPCRS and transporters)) EUB0000306b HTR2A | B | 5.8 | pKi | 1600 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | GPCRScan assay: inhibition of 5-HT2A | B | 6.6 | pKi | 251.19 | nM | Ki | Data for DCP probe PF-04457845 |
ChEMBL | GPCRScan assay: inhibition of 5-HT2A | B | 6.6 | pKi | 248.71 | nM | Ki | Data for DCP probe PF-04457845 |
ChEMBL | Selectivity interaction (GPCR panel (PDSP screen)) EUB0000306b HTR2A | B | 6.6 | pKi | 248.71 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
5-HT2B receptor/Serotonin 2b (5-HT2b) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1833] [GtoPdb: 7] [UniProtKB: P41595] | ||||||||
ChEMBL | GPCRScan assay: inhibition of 5-HT2B | B | 5.87 | pKi | 1348.96 | nM | Ki | Data for DCP probe PF-04457845 |
ChEMBL | GPCRScan assay: inhibition of 5-HT2B | B | 5.87 | pKi | 1338.44 | nM | Ki | Data for DCP probe PF-04457845 |
5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
ChEMBL | GPCRScan assay: inhibition of 5-HT2C | B | 5.78 | pKi | 1659.59 | nM | Ki | Data for DCP probe PF-04457845 |
ChEMBL | GPCRScan assay: inhibition of 5-HT2C | B | 5.78 | pKi | 1659.2 | nM | Ki | Data for DCP probe PF-04457845 |
σ2/Sigma intracellular receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4105907] [GtoPdb: 2553] [UniProtKB: Q5BJF2] | ||||||||
ChEMBL | GPCRScan assay: inhibition of Sigma 2 | B | 6.36 | pKi | 436.72 | nM | Ki | Data for DCP probe PF-04457845 |
ChEMBL | Selectivity interaction (GPCR panel (PDSP screen)) EUB0000306b TMEM97 | B | 6.36 | pKi | 436.72 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | GPCRScan assay: inhibition of Sigma 2 | B | 6.36 | pKi | 436.52 | nM | Ki | Data for DCP probe PF-04457845 |
sigma non-opioid intracellular receptor 1/Sigma opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL287] [GtoPdb: 2552] [UniProtKB: Q99720] | ||||||||
ChEMBL | GPCRScan assay: inhibition of Sigma 1 | B | 6.33 | pKi | 472.06 | nM | Ki | Data for DCP probe PF-04457845 |
ChEMBL | Selectivity interaction (GPCR panel (PDSP screen)) EUB0000306b SIGMAR1 | B | 6.33 | pKi | 472.06 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | GPCRScan assay: inhibition of Sigma 1 | B | 6.33 | pKi | 467.74 | nM | Ki | Data for DCP probe PF-04457845 |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]